Piliostigma thonningii

Piliostigma thonningii contains bioactive flavonoids, particularly luteolin and kaempferol, which demonstrate antimalarial properties through multiple mechanisms. These compounds appear to inhibit Plasmodium parasite growth and modulate immune responses. The plant's tannins and saponins contribute additional antimicrobial and anti-inflammatory effects. Laboratory studies show activity against Plasmodium species, though human clinical trials remain limited. Evidence Level: C (preliminary studies support traditional use, but more rigorous research is needed to fully understand the mechanism).

There is limited research on Piliostigma thonningii drug interactions. The plant contains tannins, which may reduce absorption of certain medications when taken concurrently. Due to potential effects on liver enzymes, caution is advised when combining with antimalarial drugs like artemisinin-based combination therapies. Patients taking prescription medications should consult a healthcare provider before use. Evidence Level: C (based on constituent properties rather than direct interaction studies).

Traditional use suggests 5-10 grams of dried bark or leaf prepared as a decoction for adults, typically divided into 2-3 doses throughout the day. Standardized extracts are not widely available, making precise dosing challenging. There is insufficient clinical evidence to establish therapeutic dosing guidelines. Evidence Level: C (based on traditional use and preliminary studies). Consult a qualified herbalist or healthcare provider for personalized guidance.

Piliostigma thonningii is contraindicated during pregnancy and should be avoided. Traditional use and preliminary studies suggest the plant may stimulate uterine contractions, potentially causing miscarriage or premature labor. The presence of saponins and other bioactive compounds raises safety concerns for fetal development. Women who are pregnant or attempting to conceive should not use this herb. Evidence Level: C (based on traditional knowledge and constituent analysis). Breastfeeding women should also avoid use due to insufficient safety data.

Piliostigma thonningii has been used traditionally in West African medicine for treating fever, malaria, and respiratory conditions. The bark and leaves are commonly prepared as decoctions for internal use or applied topically for wound healing. Indigenous knowledge systems also document its use for gastrointestinal complaints and skin infections. Evidence Level: C (traditional use is well-documented ethnobotanically, but clinical validation remains limited). Modern research has begun investigating these applications, though rigorous human trials are needed.

Reported side effects of Piliostigma thonningii are generally mild and primarily involve gastrointestinal upset, including nausea and stomach discomfort. These effects are typically associated with the tannin content and may be reduced by taking the herb with food. High doses may cause more pronounced digestive symptoms. Evidence Level: C (based on traditional use reports and constituent analysis). Discontinue use if adverse reactions occur and seek medical attention if symptoms persist or worsen.